carnitine has been researched along with methamphetamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ali, S; Binienda, Z; Gaetani, F; Imam, S; Virmani, A | 2 |
| Doi, Y; Hasegawa, T; Kitaichi, K; Matsushima, M; Morishita, Y; Takagi, K; Ueyama, J; Zhao, YL | 1 |
| Binienda, Z; Gaetani, F; Virmani, A | 1 |
| Ali, SF; Amato, A; Binienda, ZK; Przybyla, BD; Robinson, BL; Salem, N; Virmani, A | 1 |
2 review(s) available for carnitine and methamphetamine
| Article | Year |
|---|---|
Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity.
Topics: Animals; Brain; Carnitine; Cell Line; Central Nervous System Stimulants; Dopamine; Free Radicals; Methamphetamine; Mitochondria; Molecular Structure; Neuroprotective Agents | 2003 |
Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antimetabolites; Antioxidants; Carnitine; Central Nervous System Stimulants; Coenzymes; Energy Metabolism; Fatty Acids, Unsaturated; Glucose; Humans; Methamphetamine; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Ubiquinone | 2005 |
5 other study(ies) available for carnitine and methamphetamine
| Article | Year |
|---|---|
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium | 1999 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction.
Topics: Animals; Brain; Carnitine; Cell Survival; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Neurotoxins; PC12 Cells; Pheochromocytoma; Rats; Substance-Related Disorders; Tyrosine | 2002 |
Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats.
Topics: Animals; Area Under Curve; Behavior, Animal; Brain; Carnitine; Carrier Proteins; Central Nervous System Stimulants; Cimetidine; Dialysis Solutions; Gene Expression Regulation; Kidney; Male; Membrane Proteins; Metabolic Clearance Rate; Methamphetamine; Motor Activity; Myocardium; Organic Cation Transport Proteins; p-Aminohippuric Acid; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium; Time Factors; Tissue Distribution | 2003 |
Effects of L-carnitine pretreatment in methamphetamine and 3-nitropropionic acid-induced neurotoxicity.
Topics: Animals; Antihypertensive Agents; Carnitine; Dopamine Agents; Male; Methamphetamine; Neurotoxicity Syndromes; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Vitamin B Complex | 2006 |